Cancer targeting gene-viro-therapy for pancreatic cancer using oncolytic adenovirus ZD55-IL-24 in immune-competent mice

Molecular Biology Reports

Volumn 40, Issue 9, 2013, Pages 5397-5405

  He, Bin ^a,b   Huang, Xiuyan ^c   Liu, Xinyuan ^d   Xu, Bin ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

CTGVT; Immune competent; Oncolytic adenovirus; Pancreatic cancer; ZD55 IL 24

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GAMMA INTERFERON; INTERLEUKIN 6; ONCOLYTIC ADENOVIRUS; ONCOLYTIC ADENOVIRUS ZD55; ONCOLYTIC ADENOVIRUS ZD55 INTERLEUKIN 24; ONCOLYTIC VIRUS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CANCER GROWTH; CELL GROWTH; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG TARGETING; GENE EXPRESSION; GENE OVEREXPRESSION; IMMUNOCOMPETENCE; IN VITRO STUDY; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PANCREAS CANCER; REPORTER GENE; TUMOR IMMUNITY; VIRUS REPLICATION;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CYTOKINES; FLOW CYTOMETRY; GENES, REPORTER; GENETIC THERAPY; GENTIAN VIOLET; IN SITU NICK-END LABELING; INTERFERON-GAMMA; INTERLEUKINS; MICE; ONCOLYTIC VIROTHERAPY; PANCREATIC NEOPLASMS; T-LYMPHOCYTES; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84883278522     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2638-8     Document Type: Article

References (30)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA: a cancer journal for clinicians 60(5):277-300
2. Tong D, Zhou Y, Chen W, Deng Y, Li L, Jia Z, Qi D (2012) T cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and susceptibility to pancreatic cancer. Mol Biol Rep 39(11):9941-9946
3. Zhang ZL, Zou WG, Luo CX, Li BH, Wang JH, Sun LY, Qian QJ, Liu XY (2003) An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy. Cell Res 13(6):481-489
4. Mahoney DJ, Stojdl DF (2012) Fighting fire with fire: rewiring tumor cells for oncolytic virotherapy. Future Oncol 8(3):219-221
5. Bais S, Bartee E, Rahman MM, McFadden G, Cogle CR (2012) Oncolytic virotherapy for hematological malignancies. Adv Virol 2012:186512
6. Patil SS, Gentschev I, Nolte I, Ogilvie G, Szalay AA (2012) Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients. J Transl Med 10:3
7. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A, McCormick F (1996) An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274(5286):373-376
8. O'Shea CC, Johnson L, Bagus B, Choi S, Nicholas C, Shen A, Boyle L, Pandey K, Soria C, Kunich J, Shen Y, Habets G, Ginzinger D, McCormick F (2004) Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity. Cancer Cell 6(6):611-623
9. Gupta P, Su ZZ, Lebedeva IV, Sarkar D, Sauane M, Emdad L, Bachelor MA, Grant S, Curiel DT, Dent P, Fisher PB (2006) mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine. Pharmacol Ther 111(3):596-628
10. Chang S, Yang J, Chen W, Xie Y, Sheng W (2011) Antitumor activity of an adenovirus harboring human IL-24 in colon cancer. Mol Biol Rep 38(1):395-401
11. Lebedeva IV, Su ZZ, Vozhilla N, Chatman L, Sarkar D, Dent P, Athar M, Fisher PB (2008) Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiation-associated gene-7/interleukin-24 and perillyl alcohol. Cancer Res 68(18):7439-7447
12. Lebedeva IV, Sarkar D, Su ZZ, Gopalkrishnan RV, Athar M, Randolph A, Valerie K, Dent P, Fisher PB (2006) Molecular target-based therapy of pancreatic cancer. Cancer Res 66(4):2403-2413
13. Liu XY, Li HG, Yang DQ, Gu JF (2011) Strategy of cancer targeting gene-viro-therapy (CTGVT) - a trend in both cancer gene therapy and cancer virotherapy. Curr Pharm Biotechnol 13(9):1761-1767
14. Zhao L, Gu J, Dong A, Zhang Y, Zhong L, He L, Wang Y, Zhang J, Zhang Z, Huiwang J, Qian Q, Qian C, Liu X (2005) Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer. Hum Gene Ther 16(7):845-858
15. Qian W, Liu J, Tong Y, Yan S, Yang C, Yang M, Liu X (2008) Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis. Leukemia 22(2):361-369
16. Yang C, Tong Y, Ni W, Liu J, Xu W, Li L, Liu X, Meng H, Qian W (2010) Inhibition of autophagy induced by overexpression of mda-7/interleukin-24 strongly augments the antileukemia activity in vitro and in vivo. Cancer Gene Ther 17(2):109-119
17. Zhong S, Yu D, Wang Y, Qiu S, Wu S, Liu XY (2010) An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer. Acta Oncol 49(1):91-99
18. Jiang G, Zhang L, Xin Y, Pei DS, Wei ZP, Liu YQ, Zheng JN (2012) Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy. Acta Oncol 51(3):285-292
19. Kanai R, Rabkin SD, Yip S, Sgubin D, Zaupa CM, Hirose Y, Louis DN, Wakimoto H, Martuza RL (2012) Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells. J Natl Cancer Inst 104(1):42-55
20. Corbett TH, Roberts BJ, Leopold WR, Peckham JC, Wilkoff LJ, Griswold DP Jr, Schabel FM Jr (1984) Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. Cancer Res 44(2):717-726
21. Xu B, Zheng WY, Jin DY, Wang DS, Liu XY, Qin XY (2012) Treatment of pancreatic cancer using an oncolytic virus harboring the lipocalin-2 gene. Cancer 118(21):5217-5226
22. Breitbach CJ, Burke J, Jonker D, Stephenson J, Haas AR, Chow LQ, Nieva J, Hwang TH, Moon A, Patt R, Pelusio A, Le Boeuf F, Burns J, Evgin L, De Silva N, Cvancic S, Robertson T, Je JE, Lee YS, Parato K, Diallo JS, Fenster A, Daneshmand M, Bell JC, Kirn DH (2011) Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans. Nature 477(7362):99-102
23. Schmitt CA (2011) Immunotherapy: seek and destroy: oncolytic virus shows promise in phase I trial. Nat Rev Clin Oncol 8(11):630
24. Mohyeldin A, Chiocca EA (2012) Gene and viral therapy for glioblastoma: a review of clinical trials and future directions. Cancer J 18(1):82-88
25. Melcher A, Parato K, Rooney CM, Bell JC (2011) Thunder and lightning: immunotherapy and oncolytic viruses collide. Mol Ther 19(6):1008-1016
26. Cunningham CC, Chada S, Merritt JA, Tong A, Senzer N, Zhang Y, Mhashilkar A, Parker K, Vukelja S, Richards D, Hood J, Coffee K, Nemunaitis J (2005) Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Mol Ther 11(1):149-159
27. Tong AW, Nemunaitis J, Su D, Zhang Y, Cunningham C, Senzer N, Netto G, Rich D, Mhashilkar A, Parker K, Coffee K, Ramesh R, Ekmekcioglu S, Grimm EA, van Hood Wart J, Merritt J, Chada S (2005) Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol Ther 11(1):160-172
28. Dash R, Bhutia SK, Azab B, Su ZZ, Quinn BA, Kegelmen TP, Das SK, Kim K, Lee SG, Park MA, Yacoub A, Rahmani M, Emdad L, Dmitriev IP, Wang XY, Sarkar D, Grant S, Dent P, Curiel DT, Fisher PB (2010) mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity. Cytokine Growth Factor Rev 21(5):381-391
29. Dent P, Yacoub A, Hamed HA, Park MA, Dash R, Bhutia SK, Sarkar D, Wang XY, Gupta P, Emdad L, Lebedeva IV, Sauane M, Su ZZ, Rahmani M, Broaddus WC, Young HF, Lesniak MS, Grant S, Curiel DT, Fisher PB (2010) The development of MDA-7/IL-24 as a cancer therapeutic. Pharmacol Ther 128(2):375-384
30. Su Z, Lebedeva IV, Gopalkrishnan RV, Goldstein NI, Stein CA, Reed JC, Dent P, Fisher PB (2001) A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells. Proc Natl Acad Sci USA 98(18):10332-10337